CLARITHROMYCIN AUROVITAS

250MG TBL FLM 12

SÚKL code 0226336
Name of the product CLARITHROMYCIN AUROVITAS
_MA_MEDICATION_DETAIL_INFO_MED_NAME i CLARITHROMYCIN AUROVITAS
Supplement 250MG TBL FLM 12
Strenght 250MG
Pharmaceutical form Film-coated tablet
Package 12
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance CLARITHROMYCIN (CLARITHROMYCINUM)
ATC group J01FA09
ATC group name KLARITHROMYCIN

Marketing authorisation information

Registration Number 15/ 296/14-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2020
MA Holder Aurovitas Pharma Polska Sp. z o.o., Warszawa
MA Holder country POLSKO
Actual MA holder Aurovitas, spol. s r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list